Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes

Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes

Background: Multiple factors influence the survival of patients with lung adenocarcinoma (LUAD). Specifically, the therapeutic outcomes of treatments and the probability of recurrence of the disease differ among patients with the same stage of LUAD. Therefore, effective prognostic predictors need to...

Full description

Bibliographic Details
Main Authors: Rongchang Zhao, Dan Ding, Yan Ding, Rongbo Han, Xiujuan Wang, Chunrong Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Genetics
Subjects:
lung adenocarcinoma
glycolysis
nomogram
drug sensitivity
tumor mutation burden
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.828543/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.828543/full

Similar Items